PNC Financial Services Group’s Rocket Pharmaceuticals RCKT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $26.4K | Sell |
10,767
-9,897
| -48% | -$24.2K | ﹤0.01% | 3437 |
|
|
2025
Q1 | $138K | Sell |
20,664
-1,791
| -8% | -$11.9K | ﹤0.01% | 2442 |
|
|
2024
Q4 | $282K | Buy |
22,455
+6,342
| +39% | +$79.7K | ﹤0.01% | 1956 |
|
|
2024
Q3 | $298K | Buy |
16,113
+577
| +4% | +$10.7K | ﹤0.01% | 1909 |
|
|
2024
Q2 | $334K | Buy |
15,536
+768
| +5% | +$16.5K | ﹤0.01% | 1792 |
|
|
2024
Q1 | $398K | Sell |
14,768
-583
| -4% | -$15.7K | ﹤0.01% | 1679 |
|
|
2023
Q4 | $460K | Sell |
15,351
-1,495
| -9% | -$44.8K | ﹤0.01% | 1573 |
|
|
2023
Q3 | $345K | Buy |
16,846
+2,014
| +14% | +$41.3K | ﹤0.01% | 1735 |
|
|
2023
Q2 | $295K | Buy |
14,832
+480
| +3% | +$9.54K | ﹤0.01% | 1936 |
|
|
2023
Q1 | $246K | Buy |
14,352
+89
| +0.6% | +$1.53K | ﹤0.01% | 2011 |
|
|
2022
Q4 | $279K | Buy |
14,263
+1,955
| +16% | +$38.3K | ﹤0.01% | 1911 |
|
|
2022
Q3 | $196K | Buy |
12,308
+657
| +6% | +$10.5K | ﹤0.01% | 2098 |
|
|
2022
Q2 | $161K | Buy |
11,651
+3,390
| +41% | +$46.8K | ﹤0.01% | 2277 |
|
|
2022
Q1 | $131K | Sell |
8,261
-29
| -0.3% | -$460 | ﹤0.01% | 2540 |
|
|
2021
Q4 | $182K | Sell |
8,290
-347
| -4% | -$7.62K | ﹤0.01% | 2305 |
|
|
2021
Q3 | $259K | Buy |
8,637
+340
| +4% | +$10.2K | ﹤0.01% | 2023 |
|
|
2021
Q2 | $368K | Buy |
8,297
+651
| +9% | +$28.9K | ﹤0.01% | 1818 |
|
|
2021
Q1 | $338K | Sell |
7,646
-905
| -11% | -$40K | ﹤0.01% | 1840 |
|
|
2020
Q4 | $468K | Sell |
8,551
-429
| -5% | -$23.5K | ﹤0.01% | 1523 |
|
|
2020
Q3 | $206K | Hold |
8,980
| – | – | ﹤0.01% | 1913 |
|
|
2020
Q2 | $188K | Sell |
8,980
-620
| -6% | -$13K | ﹤0.01% | 1966 |
|
|
2020
Q1 | $134K | Buy |
+9,600
| New | +$134K | ﹤0.01% | 2044 |
|